<?xml version="1.0" encoding="UTF-8"?>
<ref id="B130-materials-13-04532">
 <label>130.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Pane</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Francisca</surname>
    <given-names>R.D.C.</given-names>
   </name>
   <name>
    <surname>Verhamme</surname>
    <given-names>K.M.C.</given-names>
   </name>
   <name>
    <surname>Orozco</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Viroux</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Rebollo</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Sturkenboom</surname>
    <given-names>M.C.J.M.</given-names>
   </name>
  </person-group>
  <article-title>EU Postmarket Surveillance Plans for Medical Devices</article-title>
  <source>Pharmacoepidemiol. Drug Saf.</source>
  <year>2019</year>
  <volume>28</volume>
  <fpage>1155</fpage>
  <lpage>1165</lpage>
  <pub-id pub-id-type="doi">10.1002/pds.4859</pub-id>
  <pub-id pub-id-type="pmid">31318470</pub-id>
 </element-citation>
</ref>
